Live Breaking News & Updates on Biotechnology Industry|Page 4

Stay updated with breaking news from Biotechnology industry. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Jim Simons Increases Stake in Exelixis Inc

Renaissance Technologies, led by Jim Simons (Trades, Portfolio), has recently bolstered its investment in Exelixis Inc (NASDAQ:EXEL), a notable player in the biopharmaceutical industry. The transaction, which took place on December 19, 2023, saw the firm adding 398,800 shares to its holdings, reflecting a 2.62% change in the position size. ....

United States , Financial Health , Exelixis Inc Stock Performance , Growth Prospects Of Exelixis Inc , Exelixis Inc , Renaissance Technologies , Inc Stock Performance , Growth Prospects , Joel Greenblatt , First Eagle Investment , Richard Pzena , Jim Simons , Renaissance Technologie , Jim Simons , Private Investment Firm , Biotechnology Industry , Investment Philosophy ,

Baillie Gifford Bolsters Stake in Moderna Inc

Baillie Gifford (Trades, Portfolio), a renowned investment management firm, has recently increased its investment in Moderna Inc (NASDAQ:MRNA), a leader in the biotechnology industry. This transaction has brought Baillie Gifford (Trades, Portfolio)'s total share count in Moderna to 45,654,527, representing a significant position size of 3.33% in the firm's portfolio and 11.97% of the firm's holdings in the traded stock. ....

United States , Moderna Inc , Vanguard Health Care Fund , Jefferies Group , Baillie Gifford , Growth Rank , Profitability Rank , Consumer Cyclical , Notable Investors , Health Care Fund , Ron Baron , Joel Greenblatt , Moderna Inc , Nvestment Management Firm , Biotechnology Industry ,